TY - JOUR
T1 - Interferon-regulatory factor 5-dependent signaling restricts orthobunyavirus dissemination to the central nervous system
AU - Proenca-Modena, Jose Luiz
AU - Hyde, Jennifer L.
AU - Sesti-Costa, Renata
AU - Lucas, Tiffany
AU - Pinto, Amelia K.
AU - Richner, Justin M.
AU - Gorman, Matthew J.
AU - Lazear, Helen M.
AU - Diamond, Michael S.
N1 - Funding Information:
This work was supported by the National Institutes of Health (R01 AI104972 and U19 AI083019 to M.S.D and P30 DK52574 to the Digestive Diseases Research Core Center Morphology Core), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-Science Without Borders (246513/2012-8 to J.L.P.-M), and a University Research Committee Award. We gratefully acknowledge the technical assistance of Jennifer Govero, Michelle Noll, and Soila Sukupolvi-Petty. HHS|NIH| National Institute of Allergy and Infectious Diseases (NIAID) provided funding to Michael S Diamond under grant numbers R01 AI104972 and U19 AI083019
Publisher Copyright:
© 2015, American Society for Microbiology.
PY - 2016
Y1 - 2016
N2 - Interferon (IFN)-regulatory factor 5 (IRF-5) is a transcription factor that induces inflammatory responses after engagement and signaling by pattern recognition receptors. To define the role of IRF-5 during bunyavirus infection, we evaluated Oropouche virus (OROV) and La Crosse virus (LACV) pathogenesis and immune responses in primary cells and in mice with gene deletions in Irf3, Irf5, and Irf7 or in Irf5 alone. Deletion of Irf3, Irf5, and Irf7 together resulted in uncontrolled viral replication in the liver and spleen, hypercytokinemia, extensive liver injury, and an early-death phenotype. Remarkably, deletion of Irf5 alone resulted in meningoencephalitis and death on a more protracted timeline, 1 to 2 weeks after initial OROV or LACV infection. The clinical signs in OROV-infected Irf5-/- mice were associated with abundant viral antigen and terminal deoxynucleotidyltransferasemediated dUTP-biotin nick end labeling (TUNEL)-positive cells in several regions of the brain. Circulating dendritic cell (DC) subsets in Irf5-/- mice had higher levels of OROV RNA in vivo yet produced lower levels of type I IFN than wild-type (WT) cells. This result was supported by data obtained in vitro, since a deficiency of IRF-5 resulted in enhanced OROV infection and diminished type I IFN production in bone marrow-derived DCs. Collectively, these results indicate a key role for IRF-5 in modulating the host antiviral response in peripheral organs that controls bunyavirus neuroinvasion in mice.
AB - Interferon (IFN)-regulatory factor 5 (IRF-5) is a transcription factor that induces inflammatory responses after engagement and signaling by pattern recognition receptors. To define the role of IRF-5 during bunyavirus infection, we evaluated Oropouche virus (OROV) and La Crosse virus (LACV) pathogenesis and immune responses in primary cells and in mice with gene deletions in Irf3, Irf5, and Irf7 or in Irf5 alone. Deletion of Irf3, Irf5, and Irf7 together resulted in uncontrolled viral replication in the liver and spleen, hypercytokinemia, extensive liver injury, and an early-death phenotype. Remarkably, deletion of Irf5 alone resulted in meningoencephalitis and death on a more protracted timeline, 1 to 2 weeks after initial OROV or LACV infection. The clinical signs in OROV-infected Irf5-/- mice were associated with abundant viral antigen and terminal deoxynucleotidyltransferasemediated dUTP-biotin nick end labeling (TUNEL)-positive cells in several regions of the brain. Circulating dendritic cell (DC) subsets in Irf5-/- mice had higher levels of OROV RNA in vivo yet produced lower levels of type I IFN than wild-type (WT) cells. This result was supported by data obtained in vitro, since a deficiency of IRF-5 resulted in enhanced OROV infection and diminished type I IFN production in bone marrow-derived DCs. Collectively, these results indicate a key role for IRF-5 in modulating the host antiviral response in peripheral organs that controls bunyavirus neuroinvasion in mice.
UR - http://www.scopus.com/inward/record.url?scp=84953873558&partnerID=8YFLogxK
U2 - 10.1128/JVI.02276-15
DO - 10.1128/JVI.02276-15
M3 - Article
C2 - 26468541
AN - SCOPUS:84953873558
SN - 0022-538X
VL - 90
SP - 189
EP - 205
JO - Journal of Virology
JF - Journal of Virology
IS - 1
ER -